Introduction
Oral epithelial cells are the first cells encountered by bacteria in the periodontal tissues. In addition to acting as a physical barrier against the invasion of pathogenic organisms, in inflamed sites oral (gingival) epithelial cells appear to produce several pro-inflammatory cytokines such as interleukin (IL)-1â, IL-6, IL-8 and tumour necrosis factor (TNF) [1] , indicating that the cells actively participate in the initiation and development of chronic oral inflammation. However, only a few studies [2, 3] have demonstrated cytokine production by human gingival epithelial cells and related cell lines derived from the oral cavity in response to several oral bacteria.
Recently, homologues of Drosophila Toll were found to participate in signalling of lipopolysaccharide (LPS) activity in man and mice, and were designated as Tolllike receptors (TLRs). In the initial studies on human TLRs, TLR2, but not TLR4, was suggested to mediate LPS activity [4, 5] . In subsequent studies, the dominant role of TLR4 in LPS signalling was clearly demonstrated in mice by genetic studies on TLR4-knockout mice [6] as well as genetically LPS-non-responsive C3H/HeJ and C57BL/10ScCr mice [7] [8] [9] . More recent studies on human TLRs [10] supported the critical role of TLR4 in LPS signalling. In addition, MD-2 is necessary for LPS signalling of TLR4 in human and murine cells [11, 12] . In contrast, peptidoglycan (PGN)-induced cell activation is mediated by TLR2 [13] [14] [15] . Previous studies at this laboratory revealed the dominant role of TLR4 in lipoteichoic acid (LTA) signalling [14, 16] , while other investigators suggested the involvement of TLR2 [13, 15, 17, 18] . MyD88 is an adaptor molecule for TLRs as well as IL-1 receptor (IL-1R) and IL-18R [19] [20] [21] , and most signalling of bacterial components examined to date was mediated by MyD88, although recent studies showed that LPS also activated cells in a MyD88-independent manner [22] [23] [24] . oral epithelial cells did not respond to bacterial cellsurface components even in the presence of soluble CD14 (sCD14), in contrast to human colonic epithelial cells. Previous studies [26] [27] [28] showed that human gamma-interferon (IFN-ª) primed human gingival fibroblasts (HGF) to enhance production of inflammatory cytokines upon stimulation with the LPS fraction from black-pigmented bacteria (BPB) such as Porphyromonas gingivalis and Prevotella intermedia. Furthermore, IFN-ª primed HGF which highly expressed membrane CD14 (mCD14) to increase expression of mCD14 and mRNA for CD14, TLR4 and MyD88, resulting in production of higher levels of IL-8 than non-primed cells upon stimulation with purified Salmonella LPS [29] .
This study examined the possible priming effect of IFN-ª on oral epithelial cells in relation to the production of cytokines upon stimulation with LPS, LTA and PGN and the possible regulation of the TLRMyD88 signalling pathway by IFN-ª treatment in these cells.
Materials and methods

Bacterial components and other reagents
Ultrapurified LPS from Salmonella enterica serovar Abortus-equi [30] was donated by C. Galanos (Max Plank Institut für Immunbiologie, Freiburg, Germany). LTA specimens prepared from Staphylococcus aureus and Bacillus subtilis were purchased from Sigma. These LTA specimens were slightly contaminated with extraneous LPS which was detected by a colorimetric Limulus test (Endospecy test; Seikagaku, Tokyo, Japan) as described previously [31] : 86.3 and 15.2 ng equivalent to the reference LPS of Escherichia coli O111:B4 (Difco) in 1 mg of S. aureus and B. subtilis LTA, respectively. Therefore, the repurified LTA prepared from the commercial Streptococcus sanguis specimen (Sigma) was also used as described previously [31] : Limulus activity of the LTA was ,0.1 ng equivalent= mg. S. aureus PGN was purchased from Fluka Pharmaceutical (Bechs, Switzerland). A water-soluble PGN, SEPS, was prepared from the purified PGN of S. epidermidis ATCC 155 by cleaving pentapeptide crosslinks between neighbouring stempeptide subunits with the PGN lytic endopeptidase SALE as described previously [32] . S. aureus PGN and SEPS were shown to be considerably contaminated with extraneous LPS on Limulus test: 369 and 120 ng equivalent to the reference LPS in 1 mg of S. aureus PGN and SEPS, respectively. N-Acetylmuramyl-L-alanyl-D-isoglutamine (muramyldipeptide, MDP) was supplied by Daiichi Pharmaceutical (Tokyo, Japan). Limulus activity of MDP was 0.3 ng equivalent to the reference LPS (in 1 mg of MDP). Anti-human TLR2 monoclonal antibody (MAb) TL2.1 (mouse immunoglobulin IgG2a; IgG2a) [33] was purchased from Cascade Bioscience (Winchester, MA, USA). Anti-human TLR4 MAb HTA125 (mouse IgG2a) [11] was supplied by K. Miyake and S. Akashi (University of Tokyo, Tokyo, Japan). Control mouse IgG2a was purchased from Coulter (Miami, FL, USA) and dialysed against phosphate-buffered saline (PBS). Human natural IFN-ª (antiviral activity, 8:0 3 10 6 IU=mg of protein) was provided by Hayashibara Bioscience Institute (Okayama, Japan). All other reagents were obtained from Sigma unless otherwise indicated.
Cells and cell culture
Human gingival epithelial cells were prepared from the explants of normal human gingival tissues of a 7-year-old donor with her parents' informed consent. The explants were cut into pieces and cultured in tissue culture dishes (100 mm in diameter) (Falcon; Becton Dickinson Labware, Lincoln Park, NJ, USA) in keratinocyte serum-free medium (Gibco BRL, Grand Island, NY, USA) containing bovine pituitary extract 0.05% v=w and recombinant human epidermal growth factor (820 ìM) supplemented with kanamycin (Meiji Seiyaku, Tokyo, Japan) 200 ìg=ml with a medium change every 4 days for 15-20 days until subconfluent cell monolayers were formed. Human gingival epithelial cells obtained in this manner were characterised as keratinocytes on the basis of immunostaining with anti-cytokeratin type I and II antibodies (AE1+AE3 mouse IgG1 MAb, Progen Biotechnik GmbH, Germany) as described previously [30] . These procedures were approved by the Ethical Review Board of Tohoku University School of Dentistry. The human oral epidermoid carcinoma cell line (KB cells) was provided by the Health Science Research Resources Bank (Osaka, Japan). Human oral epithelial HSC-2 cells were provided by the Cell Resource Center for Biomedical Research, Tohoku University (Sendai, Japan). KB cells were cultured in 100-mm dishes in alphamodified minimal essential medium (AE-MEM; Flow Laboratories, McLean, VA, USA) supplemented with fetal calf serum (FCS; Flow Laboratories) 10% with a medium change every 3 days. HSC-2 cells were cultured in 100-mm dishes in PRMI 1640 medium supplemented with FCS 10% with a medium change every 3 days.
As noted above, some bacterial components used in this study were contaminated with endotoxin. To rule out the possibility that the bioactivities of test materials were attributable to the endotoxin in the materials, IFN-ª-primed HSC-2 cells were also stimulated with representative test materials in the presence of polymyxin B sulphate (ICN Pharmaceuticals, Irvine, CA, USA).
RT-PCR assay
Total cellular RNA was extracted from 2:5 3 10 6 cells (one plate 100 mm diameter) by Isogen (Nippon Gene, Tokyo, Japan) according to the manufacturer's instructions. Reverse transcription of the RNA samples to cDNA was performed with AMV XL (Life Science, St Petersburg, FL, USA) and random primer (Takara, Otsu, Japan). To transcribe the total RNA into cDNA, 1.0 ìg of RNA, 50 pmol of random primer, 103 PCR buffer (Takara), 0.2 mM deoxynucleoside triphosphates and 5 U of AMV reverse transcriptase XL were added to a total volume of 20 ìl. The reaction mixture was incubated first at 308C for 10 min, next at 428C for 30 min, then 998C for 5 min to inactivate the reverse transcriptase, cooled on ice, and stored at À208C. The primers used for PCR were as follows: CD14, forward 59-CTCAACCTAGAGCCGTTTAT-39 and reverse 59-CAGGATTGTCAGACAGGTCT-39; human TLR2, forward 59-GCCAAAGTCTTGATTGATTGG-39 and reverse 59-TTGAAGTTCTCCAGCTCCTG-39; TLR4, forward 59-TGGATACGTTTCCTTATAAG-39 and reverse 59-GAAATGGAGGCACCCCTTC-39; MyD88, forward 59-TAAGAAGGACCAGCAGAGCC-39 and reverse 59-CATGTAGTCCAGCAACAGCC-39; MD-2, forward 59-GCACATTTTCTACATTCC-39 and reverse 59-CCTTACATCTTTTACACG-39; and human glyceraldehyde-3-phosphate dehydrogenase (GAPDH), forward 59-TGAAGGTCGGAGTCAACGGATTTGGT-39 and reverse 59-CATGTGGGCCATGAGGTCCACCAC-39. The primers for CD14 TLR2, TLR4, MD-2, MyD88 and GAPDH were constructed to generate fragments of 426, 368, 506, 157, 200 and 983 bp, respectively. The PCR mixtures contained 5 ìl of the cDNA mixture, 2 ìl of 103 PCR buffer, 0.2 mM deoxynucleoside triphosphates, 50 pmol of each primer, and 0.1 ìl of Ex Taq DNA polymerase (Takara, Tokyo, Japan) in a total volume of 20 ìl. Amplification was performed in a model MP TP3000 PCR thermal cycler (Takara) as follows: CD14, 25 cycles of denaturation at 948C for 1 min, annealing at 658C for 1 min and extension at 728C for 1 min; TLR2 and TLR4, 35 cycles of denaturation at 948C for 30 s, annealing at 568C for 40 s and extension at 728C for 2 min; MD-2, 35 cycles of denaturation at 948C for 30 s, annealing at 568C for 1 min and extension at 728C for 90 s; MyD88, 35 cycles of denaturation at 948C for 30 s, annealing at 608C for 40 s and extension at 708C for 2 min; GAPDH, 35 cycles of denaturation at 948C for 1 min, annealing at 608C for 1 min and extension at 728C for 1 min. Amplified samples were visualised on agarose 2.0% gels stained with ethidium bromide and photographed under UV light. The bands on the photographs were scanned and then analysed with an Image Master 1D (Pharmacia Biotech, Uppsala, Sweden). The results are expressed as relative mRNA accumulation corrected with reference to GAPDH mRNA as an internal standard.
Measurement of cytokines
Confluent epithelial cells were collected by trypsinisation and washed three times in PBS. The cells (5 3 10 4 cells=200 ìl) were seeded in culture medium 
Data analysis
All experiments were performed at least three times to confirm the reproducibility of the results, and representative results are shown. In most experiments, values are presented as means and SD of triplicate assays. The statistical significance of differences between the two means was evaluated by one-way analysis of variance (ANOVA), by the Bonferrori or Dunn method, and p values ,0.05 were considered significant.
Results
Effects of IFN-ª on production of IL-8 and GM-CSF by oral epithelial cells
First, the study examined whether oral epithelial cells produced IL-8 in response to Salmonella LPS, S. aureus and B. subtilis LTA, S. aureus PGN, a watersoluble PGN, SEPS, and MDP. In accordance with a previous report [25] , primary gingival epithelial cells, oral epithelial HSC-2 and KB cells did not secrete IL-8 in response to the bacterial components even in the presence of FCS 10% (Fig. 1b) . Under the same conditions, treatment with IFN-ª (1000 IU=ml) for 3 days made the oral epithelial cells responsive to stimulation with bacterial cell-surface components, resulting in the production of IL-8 (Fig. 1a) . Clear dose-dependency of IL-8 secretion by IFN-ª-primed HSC-2 cells was observed upon stimulation with bacterial cell-surface components (Fig. 2) . Then, the study examined the optimum concentration and duration of IFN-ª treatment required for the priming of HSC-2 cells. Marked IL-8 release in response to LPS was observed when the cells were treated with IFN-ª 1000 and 10 000 IU=ml for 3 days, whereas IFN-ª at 10 and 100 IU=ml showed only a marginal effect in this respect (Fig. 3a) . As shown in Fig. 3b , treatment with IFN-ª for 1 and 2 days was not sufficient to prime oral epithelial cells, whereas after IFN-ª priming forNext, the study examined whether IFN-ª-primed oral epithelial cells also secreted another inflammatory cytokine, GM-CSF, in response to these bacterial cellsurface components. The IFN-ª-primed HSC-2 cells markedly secreted GM-CSF upon stimulation with bacterial cell-surface components, whereas non-treated cells did not show enhanced secretion of GM-CSF (Fig. 4) .
Effect of polymyxin B on activities of LTA, PGN, SEPS and MDP
To examine the possible involvement of contaminating endotoxin in the bioactivities of the test materials, IL-8-inducing abilities of representative bacterial cellsurface components on IFN-ª-primed HSC-2 were also examined in the presence of polymyxin B. The activities of S. aureus LTA, PGN, SEPS and MDP were not inhibited but rather slightly increased by polymyxin B, whereas the activity of LPS was completely inhibited (Fig. 5) . These findings clearly indicated that bioactivities of test materials in this study are not attributable to the contaminating endotoxin.
Effects of IFN-ª on TLR2, TLR4, MD-2 and MyD88 mRNA expression in oral epithelial cells HSC-2 cells were treated with IFN-ª (1000 IU=ml) for 3 days, then RT-PCR was performed to detect levels of CD14, TLR2, TLR4, MD-2 or MyD88 mRNA expression. As shown in Fig. 6 , mRNA expression by the molecules of the TLR-MyD88 system were significantly up-regulated by IFN-ª. In contrast, the cells did not express CD14 mRNA even after treatment with IFN-ª.
Effects of anti-TLR2 and anti-TLR4 MAbs on IL-8 secretion by IFN-ª-primed HSC-2 cells in response to bacterial cell-surface components
To elucidate whether the responses of IFN-ª-primed oral epithelial cells to bacterial cell-surface components are mediated by the TLR-MyD88 signalling pathway, IFN-ª-primed HSC-2 cells were pre-incubated with anti-TLR2 MAb (10 ìg=ml), anti-TLR4 MAb (10 ìg= ml) or isotype-matched control antibody (IgG2a) (10 ìg=ml) for 30 min, then stimulated with various bacterial components. LPS-induced IL-8 secretion in IFN-ª-primed HSC-2 cells was inhibited by anti-TLR4 MAb to the control (medium alone) level, but not by anti-TLR2 MAb (Fig. 7) . The activities of S. aureus 
Discussion
This study demonstrated that treatment with IFN-ª made human oral epithelium cells responsive to bacterial cell-surface components, whereas non-treated cells showed no response even in the presence of sCD14, as reported previously [25] . There is accumulating evidence that sCD14 in serum makes mCD14-defective cells responsive to LPS [34] . This is the case in some human colonic epithelial cell lines such as SW620 and HT29 cells [25, 35, 36] but not in others such as T84 and CaCo2 cells [36, 37] . The mechanism underlying the lack of responsiveness of these epithelial cells is not clear at present.
IFN-ª exhibits various regulatory effects in different cell types [38, 39] . This group has demonstrated the priming effect of IFN-ª on human gingival fibroblasts in culture to produce inflammatory cytokines, including IL-8, upon stimulation with LPS from BPB, but not from Enterobacteriaceae [26] [27] [28] . Stříž et al. [40] reported that IFN-ª enhanced secretion of IL-8 and expression of HLA-DR and ICAM-1 by human bronchial epithelial cells. The mechanism of the priming effect of IFN-ª on oral epithelial cells to respond to bacterial cell-surface components is not clear at present. One possible explanation might be an increased number or affinity of receptor(s) other than mCD14 on oral epithelial cells as suggested by Triantafilou et al. [41] . In this context, Wan et al. [42] suggested that a potential mechanism of LPS synergy with cytokines such as IFN-ª may be attributable to up-regulation of putative LPS receptors on cells by cytokines. With regard to the possible involvement of mCD14, Funda et al. [43] reported that human intestinal epithelial cells expressed mCD14 and released sCD14, in contrast to many previous reports. However, in the present study, human oral epithelial cells did not express CD14 mRNA as determined by RT-PCR (Fig. 5 ) and mCD14 determined by flow cytometric analysis, even after treatment with IFN-ª (data not shown). Furthermore, IL-8 induced by bacterial cell-surface components on IFN-ª-primed HSC-2 cells was not inhibited by anti-CD14 MAb even in the presence of serum (data not shown). Alternatively, the priming activity of IFN-ª may be due to augmentation of the TLR-MyD88 signalling pathway, which mediates signalling not only of gram-negative but also of gram-positive bacterial cell-surface components, irrespective of CD14 [44] [45] [46] . In this context, this group confirmed that IFN-ª up-regulated mCD14 expression and MyD88 mRNA expression by human gingival fibroblasts, and resulted in enhanced production of IL-8 by the cells in response to Salmonella LPS [29] . Faure et al. reported that IFN-ª induced TLR2 and TLR4 expression in human endothelial cells. In this study, oral epithelial cells expressed TLR2, TLR4, MD-2 and MyD88 mRNA, and IFN-ª up-regulated mRNA of all the molecules to a similar extent. However, cell surface expression of these molecules could not be detected by FACS (data not shown).
To elucidate the involvement of TLRs in the response of IFN-ª-primed oral epithelial cells to bacterial components, the study examined whether the responses of IFN-ª-primed HSC-2 cells to bacterial cell-surface components were inhibited by anti-TLR2 MAb or anti-TLR4 MAb. The dominant role of TLR4 in LPS signalling was clearly demonstrated, in agreement with previous reports [7] [8] [9] [10] .
As described above, it has been suggested that both TLR2 and TLR4 are involved in LTA signalling. This group first reported that commercial LTA preparations were considerably contaminated with endotoxin and peptidoglycan, and prepared a purified LTA with bioactivity from the commercial Str. sanguis LTA by hydrophobic interaction chromatography, which was practically free from contamination with endotoxin and peptidoglycan [31] . On the other hand, Kusunoki et al.
[48] prepared a non-hydrophobic bioactive fraction different from LTA from the commercial S. aureus LTA. With the purified LTA prepared from S. aureus and Str. sanguis by the same method, Takeuchi et al. [14] demonstrated the essential role of TLR4 in LTA signalling in macrophage cultures from TLR4-knockout mice, although several investigators [13, 15, 17, 18] reported that TLR2 was a signal transducer for LTA. In this study, IL-8 secretion induced by the purified LTA from Str. sanguis as well as the commercial LTA from S. aureus in IFN-ª-primed HSC-2 cells were significantly inhibited by anti-TLR4 MAb but not by anti-TLR2 MAb. However, B. subtilis LTA-induced IL-8 secretion was inhibited by both anti-TLR2 and anti-TLR4 MAbs. These findings suggested that some LTA preparations such as B. subtilis LTA used in this study exerted TLR2-mediated activity that might be attributable to other material(s) co-existing with LTA. Recently, Gao et al. [49] reported that major activities of commercial LTA from S. aureus, Str. sanguis and B. subtilis were attributable to contaminated endotoxin in the preparations. The possibility that the bioactivities of test LTA preparations shown in this study were also attributable to endotoxin contamination of the materials was clearly ruled out for the following reasons: (i) the activity of the purified LTA from Str. sanguis, which was practically free from endotoxin contamination, was dependent on TLR4 (Fig. 7) ; (ii) the activity of S. aureus LTA was not inhibited by polymyxin B sulphate (Fig. 5 ) [25] .
S. aureus PGN-and soluble PGN, SEPS-induced IL-8 secretion was clearly inhibited by anti-TLR2 MAb, in accordance with previous reports [13] [14] [15] 50] . Although MDP is the minimal structure essential for the bioactivities of PGN, its signalling in relation to TLRs has not been elucidated. Recently, this group reported that MDP activated OCT (an analogue of the active form of vitamin D 3 )-differentiated human monocytic U937 cells, which were devoid of TLR2 on their surface [16] . In accordance with these findings, the present study found that MDP activated human oral epithelial cells in a TLR2-and TLR4-independent manner (Fig. 6 ).
Three days were required for priming oral epithelial cells by IFN-ª -a 1-2-day period was not sufficientperhaps suggesting that the priming effect of IFN-ª was an indirect effect via other mediator(s) such as inflammatory cytokines and nitric oxide (NO). In fact, it was found that IL-1â and TNF-AE also primed oral epithelial cells to respond to bacterial components (Uehara et al., unpublished observations). However, we confirmed that IL-1â and TNF-AE were not detected in the culture supernate of IFN-ª-primed cells by ELISA, and anti-NO antibody did not suppress the response of IFN-ª-primed cells to bacterial cell-surface components (Uehara et al., unpublished observations). Therefore, treatment with IFN-ª might have directly modulated intracellular function(s) of oral epithelial cells, which in turn endowed the cells with responsiveness to bacterial components, although the intracellular events are not clear at present.
Oral epithelial cells might be exposed to various inflammatory mediators in the inflamed lesions. Excessive production of IFN-ª is characteristic of immune responses mediated predominantly by Th1 lymphocytes [51] . In fact, numerous Th1 cells infiltrate into the gingival epithelium and lamina propria in inflamed gingival tissues [52] . The intraepithelial ªä T cells in chronically inflamed gingival tissues express IFN-ª [1] . Therefore, it is conceivable that in the inflamed gingival tissues, oral epithelial cells are primed with IFN-ª produced by these lymphoid cells and secrete various inflammatory cytokines in response to bacterial components such as LPS, LTA and PGN, as shown in this study, which in turn may augment periodontal inflammation.
